GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Future 3-5Y EPS without NRI Growth Rate

JW Pharmaceutical (XKRX:001060) Future 3-5Y EPS without NRI Growth Rate : 14.00 (As of May. 29, 2025)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate is 14.00.

Competitive Comparison of JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

JW Pharmaceutical  (XKRX:001060) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

JW Pharmaceutical Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XKRX:019170 XKRX:200670 XKRX:206650 XKRX:084110 XKRX:389470 XKRX:170900 XKRX:047920 XKRX:003520 XKRX:220100 XKRX:041960 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
001067:Korea 001065.PFD:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines